5 FDA Firsts From June

June 2026 brought 5 FDA firsts across infectious disease, oncology, and rare disease, expanding treatment options and addressing unmet patient needs.

June saw multiple FDA actions that marked first-of-their-kind milestones across infectious disease, oncology, and rare disease.